Award-winning Irish pharmaceutical research and development company APC, have announced a €25M investment and the creation of 120 jobs through the formation of a ‘Global Centre of Excellence for Vaccine and Advanced Therapeutic Research and Manufacturing’.
As a global ‘medicine accelerator’, APC’s expanded facility will enable the rapid research and manufacture of vaccines, including Covid-19 vaccines, and other advanced therapeutics for rare diseases.
It will provide supply chains nationally and across Europe with these vital medicines, positioning Ireland as a significant contributor on the international stage to the manufacture of Covid vaccines and other critical Advanced Therapeutics.
